[webinar] is myostatin still a potential therapeutic target? - october 2018
Published 6 years ago • 1.1K plays • Length 44:30Download video MP4
Download video MP3
Similar videos
-
![[webinar] roche/genentech anti-myostatin adnectin rg6206 in duchenne - may 2018](https://i.ytimg.com/vi/K5X7d2TAws0/mqdefault.jpg)
50:19
[webinar] roche/genentech anti-myostatin adnectin rg6206 in duchenne - may 2018
-
![bms anti-myostatin adnectin program [march 2016 webinar]](https://i.ytimg.com/vi/2T3Y7T6Oxts/mqdefault.jpg)
53:39
bms anti-myostatin adnectin program [march 2016 webinar]
-
![[webinar] what is a master protocol? - march 2018](https://i.ytimg.com/vi/SWwL6SE0FT8/mqdefault.jpg)
51:15
[webinar] what is a master protocol? - march 2018
-
![pf-06252616 (anti-myostatin) webinar [june 2015]](https://i.ytimg.com/vi/o5PQXb-iodw/mqdefault.jpg)
1:01:25
pf-06252616 (anti-myostatin) webinar [june 2015]
-
![[webinar] domagrozumab as a potential treatment for duchenne - may 2019](https://i.ytimg.com/vi/bcMHG_AONKA/mqdefault.jpg)
56:21
[webinar] domagrozumab as a potential treatment for duchenne - may 2019
-
![[webinar] summit's utrophin modulation program - january 2017](https://i.ytimg.com/vi/PajrkndUgPQ/mqdefault.jpg)
58:18
[webinar] summit's utrophin modulation program - january 2017
-
![understanding myostatin inhibition [november 2015 webinar]](https://i.ytimg.com/vi/3syf02xe45Y/mqdefault.jpg)
59:44
understanding myostatin inhibition [november 2015 webinar]
-
56:19
webinar: exploring muscle regeneration - a new approach with satellos
-
5:18
lee priest and myostatin blockers
-
4:03
bioviva journey - muscle mass and myostatin inhibition with liz parrish
-
7:37
regrowing heart muscle with stem cells
-
58:33
for-dmd study webinar (april 2015)
-
56:17
webinar: connect with the experts - genitourinary health (october 2022)
-
![webinar: sarepta therapeutics - data update from momentum study, srp-5051 [mar 2024]](https://i.ytimg.com/vi/tvnkUnSbSLg/mqdefault.jpg)
45:03
webinar: sarepta therapeutics - data update from momentum study, srp-5051 [mar 2024]
-
![[webinar] fibrogen update on pamrevlumab & enrolling non-ambulatory study - october 2017](https://i.ytimg.com/vi/lR15r4_SxIU/mqdefault.jpg)
59:30
[webinar] fibrogen update on pamrevlumab & enrolling non-ambulatory study - october 2017
-
46:01
webinar: envision study update with sarepta therapeutics
-
55:59
ppmd 2024 annual conference: day 2 - decision making around steroids, weight, and nutrition
-
37:48
advancements in cell & gene therapy -- ppmd 2023 annual conference
-
![[webinar] movedmd: a clinical trial of edasalonexent (cat-1004) in duchenne - june 2016](https://i.ytimg.com/vi/v8Zv3W0BQII/mqdefault.jpg)
43:53
[webinar] movedmd: a clinical trial of edasalonexent (cat-1004) in duchenne - june 2016
-
![[webinar] hope-2 duchenne clinical trial – capricor – july 2018](https://i.ytimg.com/vi/NpWBq8mnBOU/mqdefault.jpg)
1:09:05
[webinar] hope-2 duchenne clinical trial – capricor – july 2018
-
1:31:02
webinar: resiliency in results – what we learn when trials are terminated (september 2020)